G. Opdenakker
Cancer Research · 2000–2013
A researcher in the Science corpus: 6 papers; trusts 6 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 60 citations into it; #834 of 1,780 by trust here, #778 by citations
- Oncology — 42 citations into it
- Molecular Biology — 38 citations into it
- Hematology — 13 citations into it; #206 of 225 by trust here, #105 by citations
Whom G. Opdenakker trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Opdenakker overall
Papers from G. Opdenakker's perspective
Ordered by how strongly the researchers G. Opdenakker trusts endorse each paper. Same corpus, a different order for every researcher.
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
- New functions for the matrix metalloproteinases in cancer progression (Nature Reviews. Cancer)
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations (Science)
- Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. (Science)
- Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. (Blood)
- Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* (Journal of Biological Chemistry)
- Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. (Cell)
- The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
- Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. (Genes & Development)
- Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. (Cell)
Their papers
- Gelatinase B functions as regulator and effector in leukocyte biology (2001) — 596 citations
- Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade (2013) — 738 citations
- Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways (2013) — 1,365 citations
- Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases (2007) — 786 citations
- Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9) (2002) — 935 citations
- Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. (2000) — 736 citations